FDA gives COVID drug with Memphis ties fast-track to emergency use
The drug was created as an anti-cancer agent in collaboration with GTx, a former Memphis pharmaceutical firm.
Topics
sabizabulin Veru Inc Mitchell Steiner coronavirus COVID-19 GTx ARDSJane Roberts
Longtime journalist Jane Roberts is a Minnesotan by birth and a Memphian by choice. She's lived and reported in the city more than two decades. She covers business news and features for The Daily Memphian.
Reading comments and joining the conversation are some of the many benefits of subscribing. Join the conversation by clicking the View Comments button below. Not a subscriber? Click here.
Our commenting policy can be viewed here.